08:00 , Feb 27, 2012 |  BC Week In Review  |  Company News

Broadvector, Vectura deal

Vectura's Innovata Ltd. subsidiary granted Broadvector rights to IP covering a prodrug therapy for hip implant failure due to aseptic loosening. The therapy consists of an injection of an adenovirus serotype 5 (Ad5) vector encoding...
08:00 , Dec 13, 2010 |  BC Week In Review  |  Financial News

Broadvector withdraws IPO

Broadvector Ltd. , Melbourne, Australia   Business: Musculoskeletal, Cancer   Date announced: 11/29/10   Type: IPO   Note: The company withdrew its offering, noting that the minimum IPO fundraising threshold was unlikely to be reached....
07:00 , Oct 4, 2010 |  BioCentury  |  Finance

4Q Financial Markets Preview: Watershed moment

If biotech companies hit their milestones this quarter, the resulting stock upticks and opportunities to raise money could support both companies and investors for years. On the other hand, if things go wrong, generalists could...
07:00 , Sep 13, 2010 |  BC Week In Review  |  Financial News

Broadvector proposes IPO

Broadvector Ltd. , Melbourne, Australia   Business: Musculoskeletal, Cancer   Date announced: 9/6/10   Type: IPO   To be raised: Up to A$8.5 million ($7.8 million)   Shares: 42.5 million   Price: TBD   Overallotment:...
07:00 , Sep 13, 2010 |  BioCentury  |  Finance

IPO watch

Broadvector Ltd. , which is focused on treatments for diseases associated with aging, plans to raise up to A$8.5 million ($7.8 million) through the sale of up to 42.5 million shares at A$0.20 in an...
00:42 , Sep 8, 2010 |  BC Extra  |  Financial News

Broadvector files for IPO

Broadvector Ltd. (Melbourne, Australia) plans to raise up to A$8.5 million ($7.8 million) through the sale of up to 42.5 million shares at A$0.20 in an IPO on the Australian Stock Exchange. If sold in...